AU509621B2 - Detection, and'Prevention of Diseases caused by N, Gonorrhoeae - Google Patents

Detection, and'Prevention of Diseases caused by N, Gonorrhoeae

Info

Publication number
AU509621B2
AU509621B2 AU13321/76A AU1332176A AU509621B2 AU 509621 B2 AU509621 B2 AU 509621B2 AU 13321/76 A AU13321/76 A AU 13321/76A AU 1332176 A AU1332176 A AU 1332176A AU 509621 B2 AU509621 B2 AU 509621B2
Authority
AU
Australia
Prior art keywords
gonorrhoeae
prevention
detection
diseases caused
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU13321/76A
Other languages
English (en)
Other versions
AU1332176A (en
Inventor
C. C. and McMichael JC Brinton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dactex Inc
Original Assignee
Bactex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bactex Inc filed Critical Bactex Inc
Publication of AU1332176A publication Critical patent/AU1332176A/en
Application granted granted Critical
Publication of AU509621B2 publication Critical patent/AU509621B2/en
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/12—Nitrate to nitrite reducing bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/36—Neisseria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU13321/76A 1975-04-25 1976-04-23 Detection, and'Prevention of Diseases caused by N, Gonorrhoeae Expired AU509621B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57120075A 1975-04-25 1975-04-25
USUS57.1200 1975-04-25

Publications (2)

Publication Number Publication Date
AU1332176A AU1332176A (en) 1977-10-27
AU509621B2 true AU509621B2 (en) 1980-05-22

Family

ID=24282722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13321/76A Expired AU509621B2 (en) 1975-04-25 1976-04-23 Detection, and'Prevention of Diseases caused by N, Gonorrhoeae

Country Status (14)

Country Link
JP (1) JPS51130525A (enrdf_load_stackoverflow)
AU (1) AU509621B2 (enrdf_load_stackoverflow)
BE (1) BE841068A (enrdf_load_stackoverflow)
CA (1) CA1050423A (enrdf_load_stackoverflow)
CH (1) CH634923A5 (enrdf_load_stackoverflow)
DE (1) DE2617870A1 (enrdf_load_stackoverflow)
ES (1) ES447313A1 (enrdf_load_stackoverflow)
FR (1) FR2308377A1 (enrdf_load_stackoverflow)
GB (1) GB1549345A (enrdf_load_stackoverflow)
HU (1) HU174887B (enrdf_load_stackoverflow)
IE (1) IE44448B1 (enrdf_load_stackoverflow)
IL (1) IL49459A (enrdf_load_stackoverflow)
NL (1) NL7604311A (enrdf_load_stackoverflow)
ZA (1) ZA762438B (enrdf_load_stackoverflow)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237115A (en) * 1977-11-23 1980-12-02 Bactex, Inc. Method of immunization against enterotoxogenic infection by Escherichia coli
US4203971A (en) * 1978-03-23 1980-05-20 Government Of The United States Neisseria gonorrhoeae vaccine
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4454117A (en) * 1980-09-15 1984-06-12 Bactex, Inc. Immunization against infection by Escherichia coli
EP0049945A3 (en) * 1980-09-15 1982-12-01 Bactex Incorporated Determining a hierarchy of piliated organisms and a vaccine prepared from such organisms
DK219084D0 (da) * 1984-05-02 1984-05-02 Frederik Carl Peter Lindberg Antigen
US5132205A (en) * 1988-10-07 1992-07-21 Eastman Kodak Company High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen
GB9417880D0 (en) * 1994-09-06 1994-10-26 Auspharm Int Ltd Vaccine
JP2002527041A (ja) * 1998-04-29 2002-08-27 アメリカン・サイアナミド・カンパニー 淋菌（Ｎｅｉｓｓｅｒｉａｇｏｎｏｒｒｈｏｅａｅ）または髄膜炎菌（Ｎｅｉｓｓｅｒｉａｍｅｎｉｎｇｉｔｉｄｉｓ）に対する組換えピリンを含有するワクチン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951748A (en) * 1974-11-11 1976-04-20 Medical Products, Inc. Sensitized matrix for detection of disease

Also Published As

Publication number Publication date
HU174887B (hu) 1980-04-28
DE2617870A1 (de) 1976-12-30
ES447313A1 (es) 1977-10-16
BE841068A (fr) 1976-10-25
GB1549345A (en) 1979-08-08
CA1050423A (en) 1979-03-13
IE44448L (en) 1976-10-25
AU1332176A (en) 1977-10-27
CH634923A5 (en) 1983-02-28
ZA762438B (en) 1978-03-29
DE2617870C2 (enrdf_load_stackoverflow) 1988-09-22
NL7604311A (nl) 1976-10-27
FR2308377A1 (fr) 1976-11-19
IL49459A0 (en) 1976-06-30
JPS51130525A (en) 1976-11-12
FR2308377B1 (enrdf_load_stackoverflow) 1979-04-06
JPH0118080B2 (enrdf_load_stackoverflow) 1989-04-03
IL49459A (en) 1980-02-29
IE44448B1 (en) 1981-12-02

Similar Documents

Publication Publication Date Title
AU504383B2 (en) Netlike product
GR60789B (en) Preparation process of 2,4-dichlor-4'-benzoylureido-diphenylether and use thereof as insecticides
AU4863679A (en) Derivatives of 3-azabicyclo(3.1.0)hexane and processes
AU509621B2 (en) Detection, and'Prevention of Diseases caused by N, Gonorrhoeae
AU507918B2 (en) Catheter
AU504565B2 (en) Cyclic derivatives of 1, 4-benzoxaine and 1, 4 benzothiazine
AU503926B2 (en) 1, 3-BENZODITHIOLE-2-ONE (and 2-THIONIC) DERIVATIVES
AU499841B2 (en) 3, 5-bisoxygenated 2(w-halo-3-oxygenated -1-alkenyl)-cyclopentane-1-heptanoic acids and derivatives thereof
AU499083B2 (en) 6b 17 dihydroxy-7 (lower alkoxy) carbonyl-3-oxo-17 pregn-4-ene-21-carboxylic acid and lactones
AU501305B2 (en) N'sulfonyl-n-dihalophenylimidazolidinedioners
AU502777B2 (en) Preparation and purification of 1, 2 dichloroethane
IL49823A (en) 1-acyl-1,2,3,4-tetrahydro-6-quinolinols, their esters and preparation thereof
GB1553099A (en) Separation of 1,5-dinitroanthraquinone and 1,8-dinitroanthraquinone
AU509024B2 (en) Purified human serum prealbumin
AU505115B2 (en) N, n'diphenyl-guanidine derivatives
AU7867475A (en) Pharmaceutical composition for treatment and prevention of acute alcoholism
AU501988B2 (en) Preparation of 1- ethyl-2-[2'-methoxy-5'-sulphonamidobenzoyl] - aminomethyl pyrrolidine
AU462620B2 (en) Novel derivatives of 2,3-dihydroxypropyl-n-(7 or 8-chloro-4-quinolinyl) anthranilate
AU495632B2 (en) Preparation of 1,1- dihalo-4-methyl-pentadienes
AU494427B2 (en) Novel cyclopropylmethylamine derivatives
NZ182329A (en) Cyclohexane derivatives and pharmaceutical compositions
PH13085A (en) 4-imino-1-,3-diazabicyclo(3.1.o)-hexan-2-one,its process of preparation and pharmaceutical composition
IE44671L (en) Cyclopentanone and cyclopentenone derivatives.
AU489544B2 (en) Butyramides and butyrates
AU1311976A (en) Preparation of 1,1- dihalo-4-methyl-pentadienes